Sort by
Refine Your Search
-
siteAvailable for SecondmentNoClosing Date17-Dec-2025JD_Param11YesJD_Param12Yes Progressive multiple sclerosis (PMS) is a clear unmet need in MS therapeutics. The Optimal Clinical Trials Platform for Progressive
-
of the REFINE-MS trial, a multi-centre, phase 3 study led by Professor Olga Ciccarelli and Professor Max Parmar at UCL. The trial aims to identify the optimal dosing frequency of ocrelizumab in patients with
Searches related to optimization
Enter an email to receive alerts for optimization positions